Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes

This study is comparing an automated insulin delivery system (often called a "closed-loop" or "artificial pancreas" system) to standard insulin treatment for women with Type 1 diabetes who are pregnant or planning to become pregnant. Researchers want to see whether the automated system leads to better blood sugar control and safer pregnancies. **You may be eligible if...** - You are a woman aged 18–45 years with Type 1 diabetes for at least 12 months - You are either planning to become pregnant within 52 weeks (and have a negative pregnancy test at enrollment), OR you are already pregnant (confirmed singleton pregnancy at 8–14 weeks gestation) - You are willing to participate through delivery and up to 1 month after birth **You may NOT be eligible if...** - You are not proficient in Danish (language required for study materials) - You have severe mental health conditions or other major medical barriers as determined by your doctor - You do not meet other health criteria set by the study team Talk to your doctor to see if this trial is right for you.